Exploring general practitioners' experience of informing women about prenatal screening tests for foetal abnormalities: A qualitative focus group study
© Nagle et al; licensee BioMed Central Ltd. 2008
Received: 17 January 2008
Accepted: 28 May 2008
Published: 28 May 2008
Recent developments have made screening tests for foetal abnormalities available earlier in pregnancy and women have a range of testing options accessible to them. It is now recommended that all women, regardless of their age, are provided with information on prenatal screening tests. General Practitioners (GPs) are often the first health professionals a woman consults in pregnancy. As such, GPs are well positioned to inform women of the increasing range of prenatal screening tests available. The aim of this study was to explore GPs experience of informing women of prenatal genetic screening tests for foetal abnormality.
A qualitative study consisting of four focus groups was conducted in metropolitan and rural Victoria, Australia. A discussion guide was used and the audio-taped transcripts were independently coded by two researchers using thematic analysis. Multiple coders and analysts and informant feedback were employed to reduce the potential for researcher bias and increase the validity of the findings.
Six themes were identified and classified as 'intrinsic' if they occurred within the context of the consultation or 'extrinsic' if they consisted of elements that impacted on the GP beyond the scope of the consultation. The three intrinsic themes were the way GPs explained the limitations of screening, the extent to which GPs provided information selectively and the time pressures at play. The three extrinsic factors were GPs' attitudes and values towards screening, the conflict they experienced in offering screening information and the sense of powerlessness within the screening test process and the health care system generally. Extrinsic themes reveal GPs' attitudes and values to screening and to disability, as well as raising questions about the fundamental premise of testing.
The increasing availability and utilisation of screening tests, in particular first trimester tests, has expanded GPs' role in facilitating women's informed decision-making. Recognition of the importance of providing this complex information warrants longer consultations to respond to the time pressures that GPs experience. Understanding the intrinsic and extrinsic factors that impact on GPs may serve to shape educational resources to be more appropriate, relevant and supportive.
Recent developments have made screening tests for foetal abnormalities available earlier in pregnancy and women have a range of testing options accessible to them. It is now recommended that all women, regardless of their age, are provided with information on prenatal screening tests [1, 2]. The provision of information is an essential component in facilitating women's informed decision-making [3–6]. At a minimum, women need to understand the condition(s) for which the testing is being offered, the characteristics of the test and the implications of testing .
Health professionals need to provide women with information on both the benefits and inherent limitations of screening tests in a way that optimises understanding, without increasing their level of anxiety [7–9]. This is particularly true of tests screening for foetal abnormality where decisions on diagnostic testing and/or termination of an affected pregnancy may arise.
The quality of information women have received has been found to be variable , while women have consistently demonstrated low levels of knowledge about prenatal screening for foetal abnormalities [3, 5, 6, 10–13]. Consequently, there are challenges for all pregnancy care providers as well as implications for practice.
The introduction of screening tests in the first trimester of pregnancy has resulted in extending the role of General Practitioners (GPs). When providing confirmation of pregnancy, GPs are often the first health professional the woman consults. If this is in the first trimester, women are more likely to have all the prenatal test options available and have time to consider the information provided. As a primary health care provider the GP is well positioned to inform women of the increasing range of screening tests available.
Women value quality information that is provided by the health professional in a timely manner . This requires the health professional to have a sound understanding of the relevant issues and be able to communicate this information. While studies have focused on exploring the knowledge and attitudes of health professionals towards prenatal testing [15–18], the effect on health professionals of providing this information to women has not received much attention. The purpose of this study was to explore GPs' experience of informing women about prenatal genetic screening tests for foetal abnormality.
The study was conducted to inform the development of a decision aid for prenatal testing for foetal abnormalities, as part of a randomised controlled trial called the ADEPT (A DEcision aid for Prenatal Testing) study [ISRCTN22532458] [19, 20].
Focus groups interviews were used in preference to individual interviews as the synergistic effects of a group setting may result in the production of ideas that might not have been uncovered in individual interviews . Purposive sampling  was employed to ensure both male and female GPs from rural and metropolitan practices participated, thereby increasing the heterogeneity of experiences and perspectives. Contact details were obtained from the on-line public telephone listings and GPs from targeted geographical areas were invited to participate in the study. GPs were also recruited from a variety of professional medical organisations. The team of investigators was comprised of a midwife (CN), an associate genetic counsellor (SL), a psychologist (BM), a general practitioner (JG) and two epidemiologists (JH and RB).
Informational redundancy was reached following four focus groups and no further groups were conducted in accordance with standard qualitative methodology . The same facilitator (SL) and co-facilitator (CN) conducted all focus groups, using a semi-structured discussion guide to explore GPs' experiences. A literature review and the expertise of the project team informed the content of the question topics. The development of the discussion guide (Appendix) was informed by the method outlined by Greenwood and Parsons . Audio-tapes of the sessions were professionally transcribed and the accuracy of the transcripts was verified using the raw data and field notes.
The analysis involved a constant comparison approach , with SL and CN repeatedly reading the transcripts to develop an agreed set of codes. The analysis was also guided by the conceptual qualitative research framework of Miles and Huberman . One of the strengths of this framework lies in the explicitness of its description of qualitative data analysis, which includes the use of highly structured data displays to tease out relationships, synthesise findings and help guide against potential researcher bias. Data analyses were iterative and SL, RB & CN participated in this process to identify and agree upon emergent themes and discuss their face validity. The analysis took place concurrently with data collection, and results from each focus group were used to suggest additional lines of questioning in subsequent focus groups to ensure that divergent points of view would be expressed. The use of multiple coders and analysts and informant feedback are strategies recommended by Miles and Huberman to reduce the potential for researcher bias and increase the validity of the findings . A draft manuscript was reviewed by four GPs who participated in different groups to authenticate the findings as representative of discussions and modify accordingly. In addition, a modified version of the clustered matrices described by Miles and Huberman  was used to facilitate analysis within and across groups. A code was used to de-identify responses comprising of a sequence of two digit codes for the group and the participant. Ethics approval was obtained from the Royal College of General Practitioners, Australia (ref NREEC 03-16) to conduct the study. All participants provided written consent to participate in the study.
Two groups were held in metropolitan locations and two in regional settings in Victoria, one of the south-eastern states of Australia, where approximately 63,000 women give birth each year . In Australia the GP's role can vary from, at a minimum, confirming pregnancy and providing referral, to sharing pregnancy care with another provider (midwife, obstetrician) through to providing care in labour and the postnatal period. Prenatal care arrangements vary in different Australian States; in Victoria, women booked to give birth at publicly funded maternity services have access to a second trimester maternal serum screening test free of charge. Women in the public system who are at increased risk of foetal abnormality on the basis of their screening test result or their age (37 years or older by expected due date), are offered a funded diagnostic test at a tertiary hospital. Other screening tests, including nuchal translucency, combined first trimester screening and second trimester foetal anomaly ultrasounds, as well as diagnostic tests are available to all women on a fee for service basis.
Conceptual framework for understanding the impact of GPs' role in informing women of prenatal screening tests
Role of the GP
1. Limitations of screening
3. Time pressures
4. Potential sequelae
Bearer of bad news
6. Shifting sands
Three factors occurring within the context of the consultation were consistently evident across all groups when the topic of screening was first broached by the GP. First, the limitations of screening was a central intrinsic factor. Another was the extent to which GPs filtered the complex information, and how they facilitated decision-making based on their own perceptions of the woman's information needs. The third related to time constraints, which was a pervasive factor across all aspects of communicating screening test information.
Limitations of screening
Limitations of screening: The GP as the interpreter
"You can't leave it and say "Well we'll just do the screening and then shall we think about should we have an amnio." I think you have to actually give people an idea of what to expect before you even embark on this whole thing." 0109
"I think you've got to tell them that the test is not 100% and that's where I think it gets complicated – and that's where you've got difficulties with people who can't understand statistics -I can't even understand it." 0201
"Bottom line is there are no guarantees for anything. " 0108
"We should be explaining the greyness...... there's almost nothing that we can offer and almost nothing we can do, will have an absolutely definite black or white answer." 0109
"It needs to be made clear that the result is not foolproof -it's not absolute." 0103
"It's very hard to get that message through until they get the gold standard answer." 0301
Communicating the inherent limitations of screening tests to the woman was reported as being a challenging experience for GPs. For many GPs, central to interpreting this complex information for women was the issue of grappling with the notions of risk and uncertainty, which challenged GPs on a number of levels. Not being able to provide a definitive answer was perceived as being a particularly difficult task. For some GPs, screening test discussions exposed their own lack of confidence or skill in dealing with screening test information. Providing a pre-test probability that was meaningful and conveying that a residual risk would exist, without causing anxiety, were also identified as difficulties.
GPs identified themselves as an important source of screening test information for the woman. There was considerable variation in the amount, level and delivery of information on screening tests that GPs provided. From the transcripts it was evident that many GPs provided information to women selectively, based on their perceptions of the woman's information needs, as well as the decision-making style they used within the consultation.
Selectivity: GP as the gatekeeper
"I certainly bring it up with everybody and give the various options that are available and I suppose I tend to push depending on what age that the mothers are." 0305
"If they're old I'll tell them I want you to think about it – if they're young, the subject is raised and then come back. And they often don't come back." 0204
"I think it's not good for doctors to assume just because someone's younger they wouldn't be interested or just because someone's old they would be interested, and to try and find the right language for that is quite challenging." 0404
"I still don't think women are going to understand what's best for them – they're going to rely on you to tell them what you think is best for them." 0203
"I think we can only guide the patients to the best decision that they are going to be comfortable with." 0304
When asked who tended to raise the issue of prenatal testing, seldom was the provision of screening information explained in terms of being at the woman's initiation. When women did raise the issue of testing, it was often explained in terms of women asking for the GP's personal recommendation, "...that's a question I commonly get asked – what would I do?" 0204
Time pressures: GP as the Time keeper
"I give them written information on the first visit but I usually stress out that...time will run out, so if they don't actually make up their mind reasonably quickly..." 0103
"I didn't used to bring up screening, but now because there's a bit of pressure...timing for the tests. I do I just say are you interested in screening?" 0202
"it's a lot to go through.... not to eat various foods, and you've got to tell them not to tell the world due to the risk of miscarriage, and you've got to tell them they can't have any alcohol and there's a lot to go through so it's fitting it all in." 0303
"To really discuss things in a meaningful way and give them information that they need to make a valid decision does become a fairly lengthy process." 0305
" it's very time-consuming to try and go through the issues when they first walk in..." 0404
The GP was seen as being required to act as a 'timekeeper' because screening test information was said to take a considerable amount of time to explain. Consistently GPs related that they had insufficient time to cover the topic and that it required an entire consultation, but seldom was this possible.
The introduction of first trimester screening tests has meant that it is often not appropriate for the GP to defer a discussion of these tests. GPs described how this imperative of time had negative consequences for the woman and themselves.
The following three factors have been classified as extrinsic as they consist of elements that impact on the GP, beyond the scope of the consultation. They reveal GPs' attitudes and values to screening and to disability, as well as raising questions about the fundamental premise of testing. Extrinsic factors also include perceptions by GPs of their role within the screening test process and the health care system generally.
Potential sequelae: GP as the bearer of bad news
"I found it quite a downer. I mean they're all so excited about being pregnant and then within minutes we're talking about let's do a test to find out if you might need to terminate this pregnancy." 0304
"A lot would come in, they're overjoyed to be pregnant... and the thought of them throwing in testing for all those things that might be wrong with the pregnancy. It's a bit of a downer." 0103
"...In fact you feel like a bit of a spoilsport bringing it up because they're really happy and you know- and then your sort of saying Oh well you know I hate to bring it up but, have you thought about..." 0405
The GP was cast in the role of the 'bearer of bad news' through introducing the topic of testing which included the risk of foetal abnormality, the limitations of screening, the role of diagnostic testing and the option of termination of pregnancy in the event of a major abnormality.
Conflict: The GP as a moral agent
"I find it quite hard to be scientific and disconnected about it and yet still also taking into account someone's you know, value system." 0404
"You know some of them actually have the idea that because you're testing for it you've got to do something to fix it and they don't realize that there isn't anything you can do but terminate or decide to go through with the pregnancy." 0107
"What is meaningful information ?- even what is spina bifida really? and what is Down syndrome?.. are you going to terminate someone who has a great personality and a reasonably happy life? There are lots of issues...promoting...the perfect life, the perfect child, the perfect outcome whether we should you know – all those kind of things." 0202
"The other trick with that though is the perception of some people that it's not a risk – that it's alright to have a baby with a disability and therefore you know, how do you quantify that it's a risk you know... so how do you identify someone like that and not you know um, stir them up or upset them. It's tricky." 0404
GPs related a concern for women who would be made unduly anxious about the possibility of foetal abnormality. This was particularly true for young women where "a very large number" of young women would be "put through the anxiety" (0303) of testing for a single woman to benefit.
GPs in the role of the 'moral agent' were also concerned with the difficulty of "taking into account someone's own ethical or moral perspective"(0404). Using language that did not bring a personal value system into the consultation was viewed as troublesome.
The provision of information to women on screening tests caused some GPs to question how disability was being valued in society and whether or not they were implicated in promoting the 'perfect child'.
Shifting sands: GP as the intermediary
"There's been such massive changes in the last few years it's been hard to keep up with." 0306
"I still have some trouble on keeping up with what the changes are..." 0106
"It's not all that long ago that you tested after 37.5 years as a due date and under that you didn't sort of offer it and then it all sort of changed and now the lawyers have marched in and we now have to offer it everybody." 0303
"There's many pieces of information, but we can't all have a handle on because the ground's shifting, the tests are changing fairly rapidly.." 0304
GPs in the role of the 'intermediary' described themselves as acting as an advocate for the women, trying to empower them to make an informed choice regarding testing and avoid being coerced into testing by obstetricians who may present testing as "routine" or "compulsory".
GPs also described the frustration of poor communication from other health care providers and from problems with the screening system particularly in offering screening tests to women who are "not fully informed."
The findings of our study expose the considerable impact that informing women of prenatal screening tests for foetal abnormality has on GPs. The identification of intrinsic and extrinsic factors present a framework of describing the observed differences between factors that are contained within the consultation and factors that have a more pervasive impact on the GP. The consistency of the findings across different focus groups underscores the salience of the experience of GPs described. We propose that in order to improve women's capacity to make an informed decision about screening, attention needs to be directed to better support the GP's role.
The impact on GPs that we have described is only partially explained by their lack of knowledge. In particular, responsive professional development activities need to be directed to the complexity of factors impacting on the GP experience. Educational activities that embrace intrinsic factors should include epidemiological content and focus on communicating complex issues like 'risk' and 'uncertainty'. A framework such as the patient-centred clinical method  within an interactive learning environment could provide the opportunity for GPs to explore ways to 'find common ground' in decision-making and be less directive in the information they provide.
GPs already work within significant time constraints. Other health professionals have previously reported the intrinsic factor 'time pressures' experienced by GPs in our study when informing women of screening [29, 30]. The number of options for prenatal testing and the availability of earlier tests make extra demands on the GP's already limited time. The lack of time available to discuss prenatal testing is at odds with the increasing importance of the GP's role in informing women of screening. With the utilisation of prenatal screening increasing , it is timely to consider how to increase the amount of time allocated to consultations in early pregnancy. One option applicable to the Australian health care system might be to fund these complex discussions as long consultations, which attract a higher Medicare (Australia's publicly-funded universal health care system) rebate.
Extrinsic factors that impact on the GP beyond the scope of the consultation also warrant consideration. Our findings indicate the importance of GPs' values and attitudes to tests, screening and disability, in explaining how they experience their role in informing women. It is important that educational activities acknowledge and embrace the range of values and attitudes that exist. It may also be beneficial to consider creating forums for peer discussions about challenging experiences.
Even in a group practice, GPs often function in an isolated manner with limited opportunity to discuss issues relating to consultations. For example, during one focus group a GP revealed a professional concern to the group that the GP had not talked about previously to anyone. In light of the difficulties experienced by GPs in this study, a mechanism for GPs to share and reflect on their experiences may prove beneficial. For instance, the experience of genetic counsellors promote the benefit of 'supervision' , supporting the professional and providing a non-threatening environment to discuss psychosocial aspects of consultations.
The purpose of using a qualitative design to address this research question was to document the range of GP experiences to facilitate an in depth analysis of issues in the hope that these finding will make a valuable contribution to achieving a better understanding of GPs' experience of screening. However, only quantitative studies can unpack the degree to which these experiences and beliefs are endorsed.
This study provides a lens through which to view complex primary health consultations. Facilitating women's informed decision-making regarding prenatal screening tests requires much more from the GP than the provision of appropriate information under significant time constraints; moral dimensions also exert an influence.
An understanding of epidemiological language and communication skills is needed by GPs to assist them in providing women with meaningful information. However, it is important that the scope of future educational programs is broader than solely providing GPs with information and education. Consideration of GPs' values and attitudes may well serve to make educational resources more appropriate, relevant and supportive. Educational activities that fail to explore attitudes and values of participants to disability, screening and termination of pregnancy may be considered fundamentally flawed.
Appendix: discussion guide for focus groups
When I say the words "prenatal testing for Down syndrome", what is the first thing that comes into your mind?
Generally, how much do you think GPs know about prenatal testing?
How often does prenatal testing come up as a topic for discussion during your consultations with pregnant women?
Do you raise the issue of prenatal testing with pregnant women or do they tend to bring it up?
How do you go about discussing prenatal testing with pregnant women?
What questions do women commonly ask you about prenatal testing?
How much time do you spend in discussing prenatal testing with women?
Tell me about your recent experiences discussing prenatal testing with your patients.
What do you find most difficult about discussing prenatal testing?
What are the key points about prenatal testing that you think women need to understand in order to make a decision about what is best for them?
What resources do you use to discuss prenatal testing and how helpful are they?
Are there other resources that you use for other health related matters that you commonly use that you find useful?
When do you think would be the best time to discuss prenatal testing and hand out a decision aid?
Are there any other issues that you would like to raise?
This study was funded by Project Grant ID 237124 from the National Health and Medical Research Council, Australia. Bettina Meiser and Jane Halliday are supported by Career Development Awards from The National Medical Research Council of Australia (IDs 350989 & 216741 respectively). We acknowledge the contribution of the other ADEPT project team members: Sylvia Metcalfe and John Carlin. We are most grateful to the anonymous reviewers and all GPs who participated in the study.
- Royal Australian and New Zealand College of Obstetricians and Gynaecologists and Human Genetics Society of Australasia Joint Committee, Ellwood D, de Crespigny L, Halliday J, McLennan A, McMillan J, et al: Antenatal screening for Down syndrome and other fetal aneuploidy. Obstetrics and Gynecology. 2000, 2 (3): 185-190. [http://www.health.vic.gov.au/perinatal/downloads/annrep0304.pdf]Google Scholar
- Royal College of Obstetricians and Gynaecologists: Antenatal screening for Down syndrome. [http://www.rcog.org.uk/resources/public/pdf/down_syndrome_screening.pdf]
- Kohut RJ, Dewey D, Love EJ: Women's knowledge of prenatal ultrasound and informed choice. Journal of Genetic Counseling. 2002, 11 (4): 265-276. 10.1023/A:1016378415514.View ArticlePubMedGoogle Scholar
- Marteau TM, Dormandy E: Facilitating informed choice in prenatal testing: how well are we doing?. American Journal of Medical Genetics. 2001, 106: 185-190. 10.1002/ajmg.10006.View ArticlePubMedGoogle Scholar
- Al-Jader LN, Parry-Langdon N, Smith RJW: Survey of attitudes of pregnant women towards Down syndrome screening. Prenatal Diagnosis. 2000, 23-29. 10.1002/(SICI)1097-0223(200001)20:1<23::AID-PD746>3.0.CO;2-T.Google Scholar
- Gekas J, Gondry J, Mazur S, Cesbron P, Thepot F: Informed consent to serum screening for Down syndrome: are women given adequate information?. Prenatal Diagnosis. 1999, 19: 1-7. 10.1002/(SICI)1097-0223(199901)19:1<1::AID-PD456>3.0.CO;2-S.View ArticlePubMedGoogle Scholar
- Santalahti P, Latikka AM, Ryynanen M, Hemminki E: Women's experiences of prenatal serum screening. Birth. 1996, 23 (2): 101-107. 10.1111/j.1523-536X.1996.tb00837.x.View ArticlePubMedGoogle Scholar
- Watson M, Hall S, Langford K, Marteau TM: Psychological impact of the detection of soft markers on routine ultrasound scanning: a pilot study investigating the modifying role of information. Prenatal Diagnosis. 2002, 22: 569-575. 10.1002/pd.373.View ArticlePubMedGoogle Scholar
- Hall S, Bobrow M, Marteau TM: Psychological consequences for parents of false negative results on prenatal screening for Down's syndrome: Retrospective interview study. British Medical Journal. 2000, 320: 407-412. 10.1136/bmj.320.7232.407.View ArticlePubMedPubMed CentralGoogle Scholar
- Jaques A, Halliday J, Bell R: Do women know that prenatal testing detects fetuses with Down syndrome?. Journal of Obstetrics and Gynaecology of India. 2004, 24 (6): 647-651. 10.1080/01443610400007885.View ArticleGoogle Scholar
- De Vigan C, Vodovar V, Goujard J, Garel M, Vayssiere C, Goffinet F: Mothers' knowledge of screening for trisomy 21 in 1999: a survey in Paris maternity units. European Journal of Obstetrics, Gynecology, & Reproductive Biology. 2002, 104 (1): 14-20. 10.1016/S0301-2115(01)00559-0.View ArticleGoogle Scholar
- Mulvey S, Wallace E: Women's knowledge and attitudes to first and second trimester screening for Down's syndrome. BJOG. 2000, 107 (10): 1302-1305. 10.1111/j.1471-0528.2000.tb11624.x.View ArticlePubMedGoogle Scholar
- Grewal GK, Moss HJ, Aitken DA, Bjornsson S, Cameron AD, Pell JP: Factors affecting women's knowledge of antenatal serum screening. Scottish Medical Journal. 1997, 42 (4): 111-113.PubMedGoogle Scholar
- Carroll J, Brown J, Reid A: Women's experience of maternal serum screening. Canadian Family Physician. 2000, 46: 614-620.PubMedPubMed CentralGoogle Scholar
- Hemminki E, Santalahti P, Toivianen H: Impact of prenatal screening on maternity services - Finnish physicians' opinions. Acta Obstetricia et Gynecologica Scandinavica. 1999, 78 (2): 93-97. 10.1034/j.1600-0412.1999.780204.x.View ArticlePubMedGoogle Scholar
- Ormond K, Gill C, Semik P: Attitudes of health care trainees about genetics and disability: Issues of access, health care communication, and decision making. Journal of Genetic Counseling. 2003, 12 (4): 333-349. 10.1023/A:1023953022290.View ArticlePubMedGoogle Scholar
- Rostant K, Steed L, O'Leary P: Prenatal screening and diagnosis: A survey of health care providers' knowledge and attitudes. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2003, 43: 307-311. 10.1046/j.0004-8666.2003.00079.x.View ArticlePubMedGoogle Scholar
- Tyzack K, Wallace E: Down syndrome screening: What do health professionals know? . Australian and New Zealand Journal of Obstetrics and Gynaecology. 2003, 43: 217-221. 10.1046/j.0004-8666.2003.00070.x.View ArticlePubMedGoogle Scholar
- Nagle C, Lewis S, Meiser B, Metcalfe S, Carlin J, Bell R, Gunn J, Halliday J: Evaluation of a decision aid for prenatal testing of fetal abnormalities: a cluster randomised trial . BMC Public Health. 2006, 6: 96-10.1186/1471-2458-6-96.View ArticlePubMedPubMed CentralGoogle Scholar
- Nagle C, Gunn J, Bell R, Lewis S, Meiser B, Metcalfe S, Ukoumunne OC, Halliday J: Use of a decision aid for prenatal testing of fetal abnormalities to improve women’s informed decision making: A cluster randomised controlled trial . BJOG. 2008, 115 (3): 339-347. 10.1111/j.1471-0528.2007.01576.x.View ArticlePubMedGoogle Scholar
- Stewart D: Focus groups: Theory and practice. 1990, Newbury Park , SageGoogle Scholar
- Patton M: Qualitative Evaluation and Research Methods. 1980, Newbury Park , Sage, 2ndGoogle Scholar
- Greenwood J, Parsons M: A guide to the use of focus groups in health care research: Part 2. Contemporary Nurse. 2000, 9: 181-191.View ArticlePubMedGoogle Scholar
- Glaser BG, Strauss AL: The Discovery of Grounded Theory: Strategies for Qualitative Research. 1973, Chicago , AldineGoogle Scholar
- Miles MB, Huberman AM: Qualitative data analysis: An expanded sourcebook. 1994, London , Sage, 2ndGoogle Scholar
- Riley M, Davey MA, King J: Births in Victoria 2003-2004. 2005, Melbourne, Perinatal Data Collection Unit, Public Health, Victorian Government Department of Human Services , Report No.: ISBN: 0731162250, [http://www.rcog.org.uk/resources/public/pdf/down_syndrome_screening.pdf]Google Scholar
- Calman KC, Royston GHD: Risk language and dialects. British Medical Journal. 1997, 315 (7113): 939-942.View ArticlePubMedPubMed CentralGoogle Scholar
- Stewart M, Weston WW, Brown JB: Patient-Centered Medicine: Transforming the Clinical Method. 1995, Thousand Oaks , SageGoogle Scholar
- Williams C, Alderson P, Farsides B: Too many choices? Hospital and community staff reflect on the future of prenatal screening. Social Science and Medicine. 2002, 55 (5): 743-753. 10.1016/S0277-9536(01)00200-3.View ArticleGoogle Scholar
- Green JM: Serum Screening for Down's syndrome: Experience of obstetricians in England and Wales. British Medical Journal. 1994, 309: 769-772.View ArticlePubMedPubMed CentralGoogle Scholar
- Muggli E, Halliday J: Prenatal diagnostic testing and Down syndrome in Victoria 1992-2002. Aust N Z J Public Health. 2004, 28 (5): 465-470.PubMedGoogle Scholar
- Kennedy A: Supervision for practicing genetic counselors: An overview of models. Journal of Genetic Counseling. 2000, 5.Google Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6963/8/114/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.